Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-50
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to find out how cancer treatments (chemotherapy and/or radiation therapy) affect reproductive and sexual health in people with early onset colorectal cancer. The study researchers will observe and track changes in hormone levels and in sexual and reproductive health in people with early onset colorectal cancer. This information will help researchers know more about how cancer treatments affect reproductive and sexual health, including the ability to have children (fertility).
Eligibility criteria
Qualifiers
18-40 years of age and premenopausal (female) or 18-50 years of age (male) at time of diagnosis
Histologic diagnosis of colorectal adenocarcinoma
Able and willing to participate in the informed consent process
Eligible for curative adjuvant or neoadjuvant therapy for colon or rectal cancer
Disqualifiers
Prior systemic treatment for this malignancy
Active or prior secondary malignancy
History of ovarian resection (if female)
Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception until the termination of gestation, confirmed by a positive hCG laboratory test.
Trial design
Treatments tested in this trial
- Hormone biomarker analysis
- QoL Questionnaires
Treatment groups
120 Participants
are divided into 2 treatment groupsLocations
7Memorial Sloan Kettering Basking Ridge07920, Basking RidgeNew Jersey, United States
Memorial Sloan Kettering Monmouth07748, MiddletownNew Jersey, United States
Memorial Sloan Kettering Bergen07645, MontvaleNew Jersey, United States
Memorial Sloan Kettering Cancer Center at Suffolk - Commack11725, CommackNew York, United States
Sponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
Source ClinicalTrials.gov